Browsed by
Category: Blood

Changes in Cholesterol & triglyceride may affect dementia.

Changes in Cholesterol & triglyceride may affect dementia.

Researchers looked into the impact of varying triglyceride and cholesterol levels on dementia risk.

They discovered that varying amounts of triglycerides and cholesterol raise the incidence of dementia by 19% and 23%, respectively. To comprehend how these results might influence patient treatment, more investigation is required.

Globally, dementia affects around 55 million individuals. This number is anticipated to nearly quadruple to 152 million by 2050 as the world’s population ages.

Strategies for dementia prevention are essential for maintaining health. Finding techniques to mitigate potential risk factors that raise the likelihood of dementia is one way to develop these solutions.

Regular medical care includes tests for triglyceride and cholesterol levels. In order to create hormones and cells, the liver produces a form of fat called cholesterol. A form of fat used for energy is triglycerides.

Clinicians may be able to screen patients for dementia risk and maybe stop or delay the start of the disease by looking at the relationship between blood lipids and dementia risk.

Some evidence suggests a connection between cholesterol fluctuation and dementia. Despite conflicting findings in studies on whether high cholesterol levels increase dementia risk.

Future dementia screening methods and treatments may benefit from a deeper understanding of which lipid components raise dementia risk.

To evaluate whether there is a connection between cholesterol levels and the risk of dementia, researchers recently examined medical records.

“While not necessarily altering practice, this study highlights the need to pay close attention to people with fluctuating cholesterol levels. It will need more research to ascertain if this variance is a real factor in the onset of Alzheimer’s disease or only a side effect of dementia,” said Dr. Dmitriy Nevelev, associate director of cardiology at Staten Island University Hospital and a non-participant in the study.

High risk of dementia associated with fluctuating cholesterol

The average age of the 11, 571 participants the researchers gathered for the study was 71. 54% of the participants were female, and none had ever been diagnosed with Alzheimer’s disease or another type of dementia.

All of the individuals had their blood lipid levels checked for several factors at least three times in the five years before to the study. These comprised:

  • cholesterol overall
  • triglycerides
  • LDL, short for low-density lipoprotein cholesterol
  • HDL stands for high-density lipoprotein cholesterol.

Following the participants lasted an average of 12.9 years. 2,473 people experienced the onset of dementia during this time.

Based on how much the individuals’ blood lipid measurements changed, the researchers divided the people into five groups.

In the end, they discovered that those with total cholesterol variability in the highest 20% band had a 19% increased risk of dementia compared to those in the lowest 20%.

Those with triglycerides in the top 20% of the range had a 23% higher risk of dementia than those in the bottom 20%.

The findings persisted after taking into account potential confounding variables like education, initial cholesterol levels, and adherence to lipid-lowering therapies, according to the researchers. They also discovered that changes in HDL and LDL did not correspond to a higher risk of dementia.

Why are changes in lipid levels important?

We discussed how varying triglyceride and cholesterol levels may raise the risk of dementia with Dr. James Giordano, Pellegrino Centre professor of neurology and biochemistry at Georgetown University Medical Centre who was not involved in the study.

He stated that it is unclear whether or how varying cholesterol levels affect the risk of dementia. Nevertheless, he talked about plausible mechanisms from his own study.

According to Dr. Giordano’s research, “a number of blood-borne factors may cause changes in inflammatory mediators that affect cerebral blood vessels, nerve, and glial cells of the brain cells that remove waste from the brain and deliver nutrients to neurons.”

“This shift to a pro-inflammatory phenotype might interact with existing genetic predispositions in certain individuals. This may increase the risk of several neurodegenerative diseases, including some types of dementia,” he said.

Dr. Nevelev concurred that there is currently no conclusive explanation for why cholesterol fluctuation may raise the risk of dementia.

The functioning of our blood vessel lining is impaired by endothelial dysfunction, which is caused by cholesterol variability. This impairment contributes to irregular blood flow. According to Dr. Nevelev, “Cholesterol variability is also associated with [the] instability of blood vessel plaque, which can likewise obstruct blood flow and harm brain tissue.

He continued, “This study seeks to account for another possibility, which is the effect of sporadic adherence with cholesterol-lowering medicine.

The study did not take into consideration every factor.

We requested an explanation of the study’s main shortcomings from Dr. Howard Pratt, a board-certified psychiatrist and medical director of Community Health of South Florida who was not engaged in the investigation.

“The study’s participants had higher levels of comorbidity than the non-study control group, which did not. Therefore, there can be confounding factors that are harder to identify. Another drawback of the study is that it only included participants from one area, so it’s still not clear whether the conclusions apply to the entire community, the author pointed out.

The apolipoprotein-E (Apo-E) gene, which may have impacted the results of the study, is one genetic risk factor for dementia that was not taken into consideration, according to Dr. Giordano.

Dr. Nevelev was questioned about the study’s constraints as well. He pointed out that it is vital to know whether triglyceride levels were evaluated in samples that were fasting or samples that were not, as triglyceride levels change while a person is fasting.

He continued by saying that variations in body weight are associated with poor health outcomes and that triglyceride and cholesterol levels are related to body weight.

The researcher said, “It is possible that the observation in this study is reversed perhaps those in the early stages of dementia have changes in behaviour or changes in body weight that lead to significant variation in triglyceride levels.”

What effects does this have on preventing dementia?

UTHealth Houston’s McGovern Medical School professor of neurology and director of the Neurocognitive Disorders Centre, Dr. Paul E. Schulz, who was not engaged in the study, said the following to us:

How to apply the findings of this study to the real world is one important question. There are numerous drugs available that lower triglycerides or cholesterol, but I am not aware of any that do the same for fluctuations. Conversely, nutrition has a huge role in managing diabetes. I also wonder if dietary adjustments could also assist lower triglyceride or cholesterol fluctuations, which would lower the risk of dementia.

But given the overwhelming evidence that lower cholesterol is linked to a lower risk of Alzheimer’s disease, he added, “I would still advise people at risk for Alzheimer’s disease to think about taking their statin if their doctor prescribes it to lower their risk for developing Alzheimer’s disease.”

REFERENCES:

For Cholesterol medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=47

Epilepsy risk is 2.5 times higher in hypertensive people.

Epilepsy risk is 2.5 times higher in hypertensive people.

Researchers looked into the connection between epilepsy and high blood pressure. They discovered that taking antihypertensive drugs lowers the risk of epilepsy. This is increased by high blood pressure by about 2.5 times.

They come to the conclusion that while high blood pressure is a risk factor for epilepsy, further research is required to fully understand the mechanisms that underlie the association.

Ablestock

After stroke and dementia, epilepsy is the third most prevalent neurological illness that affects elderly individuals.

According to research, late-onset epilepsy has increased in prevalence over the past 20 years. As the population ages, the prevalence of the disorder will undoubtedly continue to climb. This makes epilepsy a substantial public health concern.

Despite this, 32-48% of cases of epilepsy have unknown underlying causes. According to several studies, vascular risk factors may raise the chance of developing late-onset epilepsy. According to another study, epilepsy may be caused by vascular risk factors starting in a person’s 30s.

Policymakers may be better able to develop public health initiatives and preventive actions to lower and manage rates of the condition if they have a better understanding of the involvement of vascular risk factors in late-onset epilepsy.

A recent investigation of the relationship between vascular risk factors and the start of epilepsy was conducted by researchers in the United States under the direction of the Boston University School of Medicine.

They discovered a connection between hypertension and a nearly 2-fold increased incidence of late-onset epilepsy. For those who did not use medication to control their blood pressure, this risk was significantly larger.

Data evaluation

Data from the Framingham Heart Study (FHS), an ongoing, community-based study that started in 1948, was used by the researchers. Through health exams every four years, the Offspring Cohort follows the health outcomes of 5,124 of the children of the original participants.

The researchers combined data from 2,986 individuals who underwent their fifth checkup between 1991 and 1995, were at least 45 years old at the time, and whose health records contained information on vascular risk factors.

Systolic and diastolic blood pressure were measured as vascular risk factors. The researchers defined high blood pressure as having a systolic pressure of at least 140 millimeters of mercury (mm Hg) and a diastolic pressure of at least 90 mm Hg, as well as taking antihypertensive drugs.

Additionally, the researchers looked for:

  • diabetes
  • cholesterin amounts
  • smoking history
  • a cardiovascular condition
  • stroke
  • BMI, or body mass index

The ICD-9 codes associated with epilepsy or seizures, self-reported seizures, routine chart reviews for neurological diseases, and antiepileptic medication use were utilised by the researchers to screen participants for epilepsy or seizures.

To identify cases of epilepsy, the researchers also analysed electroencephalography (EEG), cardiac, and other pertinent data, as well as brain imaging.

The study found 55 cases of epilepsy in the group, of which 26 were confirmed, 15 were likely, and 14 were suspected. The average age of the subjects at the time of a possible diagnosis was 73.8 years old.

The study’s findings revealed a nearly 2-fold increased risk of epilepsy in people with hypertension. The other risk variables, however, were unrelated to epilepsy.

They also discovered that the probability of having epilepsy increased by 17% for every 10 mm Hg change in systolic blood pressure.

Underlying processes

The connection between epilepsy and hypertension is explained by several theories. The renin-angiotensin system (RAS), which controls blood pressure, may be one mechanism.

According to research, rats who have had repeated seizures had 2.6–8.2 times the RAS components of seizure-free mice. Antihypertensive medications that decreased RAS component levels postponed the start of seizures and decreased their frequency.

More investigation is required, though, as other studies indicate the system may only have a modest impact on the relationship between epilepsy and hypertension.

Small vascular disease (SVD), a disorder in which the walls of small arteries and capillaries are damaged and do not adequately convey oxygen-rich blood to numerous organs, is another potential underlying mechanism, claim the researchers. According to a recent study, the duration of high blood pressure is a reliable indicator of developing SVD in later life.

The researchers also mention that temporal lobe epilepsy and SVD are related. Cortical microinfarcts, tiny lesions in the cortical tissue, and the disruption of U fibers are a few potential explanations. These conditions may cause excessive excitability and hence seizures. U fibers link adjacent regions of the cerebral cortex.

The researchers draw the conclusion that hypertension is a standalone predictor of late-onset epilepsy and carries a 2-fold chance of getting seizures after 45 years.

They do acknowledge that their study has some limitations. It might not accurately represent all races and ethnicities because it was mostly made up of white people. The study’s observational design, according to the researchers, precludes the ability to establish causality.

Dr. Jason Hauptman, a neurosurgeon at Seattle Children’s Hospital, told us that these findings were particularly intriguing because there has been debate over whether elevated blood pressure (hypertension) is a standalone risk factor for stroke.

living with high blood pressure and epilepsy

A healthy blood pressure reading is less than 120/80 mmHg; if you are unsure of your current blood pressure, ask your doctor. High blood pressure is closely linked to a variety of health risks, including cardiac arrest, so it is important to try and maintain this level. The good news is that there are lots of easy lifestyle adjustments you can make to lower your blood pressure, like:

  • healthy eating
  • not a smoker
  • controlling stress
  • lowering the consumption of alcohol
  • Exercising
  • consuming less salt

Speak to your doctor if you have concerns about your epilepsy and high blood pressure. They can assist you in creating a management strategy to lower your blood pressure through dietary and activity modifications. while also making sure that you are controlling your seizures.

REFERENCES:

For Epilepsy disease treatments that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=49

Higher doses of Ozempic improve blood sugar, weight loss?

Higher doses of Ozempic improve blood sugar, weight loss?

According to experts, glucagon-like peptide 1 (GLP-1) medications like Ozempic, often referred to as semaglutide, can aid in weight loss in those who are obese.

For weight loss, Ozempic is not FDA-approved. There is also the brand Wegovy, which is semaglutide.

Wegovy and Ozempic should not be used by persons who are not diabetic or obese for any reason, including to shed minor amounts of weight, according to experts.

In the latter part of 2017, the FDA approved the use of the GLP-1 medication Ozempic in people with type 2 diabetes. But lately, it’s made news for other reasons as well: Benefits of purported weight loss and scarcity.

“People are talking about them because there is a trend where celebrities and influencers are increasingly turning to off-label use of GLP-1 medications like Ozempic for weight loss by people who are not obese or diabetic,” claims Dr. Rekha Kumar, an endocrinologist in New York City and the head of medical affairs at the weight management program Found.

This, according to Kumar, is very troubling.

“The trend of medispas, boutique weight-loss clinics, and illegal telehealth businesses liberally prescribing to people who don’t meet criteria is not only irresponsible prescribing, but it may also prevent the medication from reaching those who need it most,” Kumar claims.

By responding to the following frequently asked questions regarding Ozempic, Kumar and other professionals distinguished fact from fantasy.

What is Ozempic?

Dr. Angela Fitch, FACP, FOMA, president of the Obesity Medicine Association and chief medical officer of knownwell, a weight-inclusive healthcare firm, says that Ozempic is a brand name for the medication recognised as semaglutide.

Ozempic is an injectable medicine for persons with type 2 diabetes, according to Kumar. The FDA first approved it for 0.5 mg or 1 mg dosages. The FDA authorized a higher dose of 2 mg in 2022.

According to Kumar, it helps the pancreas produce insulin, which decreases blood sugar levels.

Adverse effects of semaglutide

All GLP-1 medications, as pharmacological agents, have the potential to have side effects, according to Dr. Jay Shubrook, professor of the Primary Care Department at Touro University in California.

According to Dr. Shubrook, these “are frequently dose-dependent and can be more obvious during dose changes.”

In any case, typical adverse effects of semaglutide “include an excessive loss of appetite, nausea, and less frequently, vomiting or diarrhoea. Most patients only experience temporary adverse effects, he noted.

He pointed out that teaching patients to eat slowly and mindfully, as well as how to control their portions, can lessen the negative effects of semaglutide.

Is Ozempic an FDA-approved weight-loss product?

No. “Ozempic is only approved for diabetes,” claims Dr. Charlie Seltzer, a Philadelphia-based medical professional who is board-certified in both internal medicine and obesity.

But here’s where some of the ambiguity arises. “The active ingredient, semaglutide, is approved for weight loss under the trade name Wegovy,” claims Seltzer.

Elon Musk tweeted about Wegovy’s assistance with his weight loss in October 2022.

Distinction between Wegovy and Olympic

Semaglutide and injectables are both sold under the trade names Ozempic and Wegovy. They aren’t precisely the same, though.

“Wegovy is FDA-approved for the treatment of overweight and obesity,” claims Kumar. “Wegovy was developed specifically for the treatment of overweight and obesity,” according to the manufacturer. “It contains a higher dose of semaglutide, [2.4 mg], than Ozempic.”

Does Ozempic aid in shedding pounds?

Kumar points out that Wegovy’s dosing was employed in the studies on semaglutide and weight loss, including one from 2021 that showed that once-weekly doses of 2.4 mg of semaglutide could lower body weight when paired with dietary and lifestyle modifications.

“[In the] study,] those who took the medication and made lifestyle changes lost almost 15% of their body weight, on average, compared to 3% in the placebo group,” Kumar claims.

So certainly, semaglutide may aid in weight loss, at least at a greater dose of 2.4 mg. Although Seltzer observes that the two medications function similarly, it is uncertain whether the 0.4 mg dosage difference between Ozempic and Wegovy is significant.

As food takes longer to leave the stomach and suppresses hunger, ozempic prolongs satiety, according to Seltzer. “It does nothing magical to the metabolism.”

In addition, Kumar points out that despite what some celebrities and social media influencers may say, these medications are not intended for those who just want to drop a few pounds.

“Normal-weight patients without diabetes might lose weight if they take GLP-1s, but the risks of the medication outweigh the benefit of weight loss just to be thin versus treating a disease,” says Kumar. “GLP-1s have not been studied in this population, and with this type of inappropriate use, we probably will see more side effects.”

Is Ozempic safe?

For adults with type 2 diabetes, ozempic is typically regarded as safe in doses up to 2 mg, however doctors agree that some people shouldn’t take it.

“It should be avoided in many populations, including but not limited to people with a history of pancreatitis, people who have had medullary thyroid cancer, or who are at increased risk for medullary thyroid cancer,” says Seltzer.

If you are a good candidate for Ozempic, your doctor can help you decide. Furthermore, some persons might suffer negative effects. According to Fitch, typical ones include:

  • nausea
  • constipation
  • dizziness
  • reduction in appetite
  • diarrhea

Can you regain weight after using semaglutide?

Patients who quit taking 2.4 mg dosages of semaglutide had gained back two-thirds of the weight they had lost one year after stopping, according to a trial of nearly 2,000 patients published in 2022.

The same problems that got the people into difficulty in the first place will still exist once the drug is stopped or loses its effectiveness, according to Seltzer, and the weight will quickly regain.

Fitch concurs,

Whatever you do personally to aid in weight loss, Fitch advises, “You have to keep doing it, or the weight will come back.” “The human body was created in this manner. It is constructed to safeguard its weight at all costs. Care for the elderly is crucial.

“Since obesity is a chronic disease, you must treat it chronically, ongoingly, and in a coordinated, comprehensive way,” adds Fitch. For a comprehensive approach to metabolic health, weight control, and primary care, patients must collaborate with their doctor.

What other therapies are there for obesity?

First, Fitch emphasises the need of being nonjudgmental and emphasising joint decision-making in all obesity treatments.

According to Fitch, “obesity is a lifelong chronic disease and should be treated in a compassionate and thorough patient-centered way, such as shared decision making around taking medication or having surgery with the risks and benefits in mind.”

Although diet and exercise are frequently suggested as first-line therapy, they are not always effective.

“Obesity is a complex disease with many factors,” explains Fitch. “We add in other treatments to help patients live longer, healthier, better quality lives when lifestyle changes are not enough.”

REFERENCES:

For Weight loss medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=20

Avoid hypertension and heart disease with Japanese plump.

Avoid hypertension and heart disease with Japanese plump.

Globally, almost 1.3 million people suffer from high blood pressure. Additionally, the top global risk factor for death is hypertension. One is greatly at risk for developing various forms of heart disease if they have high blood pressure.

Juice concentrate is made from the Japanese plum, according to Temple University researchers. It may aid persons with hypertension who are at risk for cardiovascular disease.

The juice concentrate was also discovered by scientists to help prevent the development of hypertension.

High blood pressure, sometimes referred to as hypertension medically, affects about 1.3 million people worldwide. This makes it the leading cause of mortality.

According to research, having high blood pressure increases the chance of other cardiovascular conditions such as atrial fibrillation, heart failure, stroke, and coronary heart disease.

Currently, Temple University researchers think that the Japanese plum juice concentrate can help lower cardiovascular disease risk in persons with hypertension and may even help prevent high blood pressure. A mouse model was used for the investigation.

Is it possible for Japanese plum to lower blood pressure?

It is customary in Japan to use the word “ume” to refer to the Japanese plum, or Prunus mume, also known as the Japanese apricot.

For use in wine or juice beverages, it is occasionally transformed into an infused juice concentrate. It is known as bainiku-ekisu.

This study’s senior author, Dr. Satoru Eguchi, is a professor in the Cardiovascular Research Centre at the Sol Sherry Thrombosis Research Centre and Centre for Metabolic Disease Research at the Lewis Katz School of Medicine at Temple University. He said the study was motivated by the need for treatments other than prescription medications for hypertension.

Even while they normalise blood pressure, he told us, “current treatments are insufficient to normalise the risk of cardiovascular disease death and incidences like myocardial infarction or stroke.” “Compared to subjects with normal blood pressure, hypertension patients have a higher risk for cardiovascular disease regardless of treatment or drug-induced blood pressure normalisation.”

Researchers claim that prior studies in blood vessel smooth muscle cells shown that bainiku-ekisu helped prevent angiotensin II-induced signals that promote proliferation. Circulatory hormone angiotensin II is recognised to contribute to the emergence of hypertension.

Angiotensin II is a major hormone (regulating) blood pressure and contributes to the development of hypertension in humans,” stated Dr. Eguchi. In cultured vascular cells, our earlier study showed that it reduced angiotensin II signaling and function. All other fruit extracts failed to change the effects of angiogenic factors in these cells. Our in vitro results, however, were somewhat limited. Thus, we proposed the hypothesis that it might lower blood pressure. Also, the related vascular issues are caused by hypertension in vivo.

Preventing the development of cardiovascular disease

Dr. Eguchi and his team tested their hypotheses on the ume juice concentrate, bainiku-ekisu, using a mouse model for this study.

Angiotensin II was infused into mice to raise their blood pressure. The mice were then given water that either contained bainiku-ekisu or normal water.

Analysis revealed that mice who drank the water with bainiku-ekisu did not develop hypertension.

The Dainik-kiss additionally assisted in shielding their vasculature from the damaging effects of angiotensin II. For instance, mice given the juice concentrate only experienced slight aortic hypertrophy. Whereas mice given normal water experienced severe aortic hypertrophy.

The researchers also discovered that bainiku-ekisu assisted in reducing immune cell levels, which would typically lead to an inflammatory process connected to hypertension.

Additionally, scientists found that bainiku-ekisu prevented the cellular switch from aerobic metabolism to glycolysis which is typically seen in hypertension. This aids in preventing the body from suffering from oxidative stress, which can lead to inflammation, vascular stiffness, and even the emergence of more serious cardiovascular disease.

According to Dr. Eguchi, “Our animal studies indicate that bainiku-ekisu may lower blood pressure in patients with hypertension.” “It is okay to mix with standard treatment. Reducing the amount of medication required to maintain normal blood pressure may also be helpful.

Additionally, he continued, “Taking bainiku-ekisu may help you avoid complications related to hypertension, like heart attack and stroke.”

Previous studies on the health advantages of ume

The Japanese plum is grown on a tree that, like cherry trees, blooms with plum blossoms in the spring, ushering in festive occasions in Japan.

In warm to subtropical climates, Japanese plum trees thrive. The Japanese plum has been grown for thousands of years in China and Japan, but it has also spread to other regions of the world, including sections of the United States.

The Japanese plum has a taste that is more acidic and tart even though it resembles Western plums or apricots in appearance and scent.

The Japanese plum is frequently used to make umeboshi, which is a highly salted and pickled plum that is used as a condiment in conventional Japanese cuisine, in addition to being processed into the infused juice concentrate known as bainiku-ekisu.

Japanese plum has previously been investigated for its potential health advantages. According to earlier studies, ume may aid those who experience the symptoms of gastroesophageal reflux disease (GERD) with their digestive problems.

Other research have revealed that ume contains anti-inflammatory and antioxidant effects and may help prevent obesity and allergy disease.

Additionally, a 2017 study discovered that persons with grade I hypertension who consumed ume extract daily saw an improvement in their diastolic blood pressure.

Study restrictions and conclusions

In addition, we discussed the latest findings with Dr. Rigved Tadwalkar, a board-certified cardiologist at Providence Saint John’s Health Centre in Santa Monica, California.

Although it was conducted on mice, he said, “what’s interesting is that bainiku-ekisu was able to attenuate hypertension and protect against vascular remodelling, which is really quite positive.”

Dr. Tadwalkar did advise caution, however, because there is still much to learn about ume and bainiku-ekisu as potential remedies.

“This is somewhat novel, and mouse models don’t always reflect the complex pathophysiology of human cardiovascular disease,” he said. Therefore, it is evident that human testing would be necessary to establish the effectiveness, safety, and dosage for controlling this.

Dr. Tadwalkar continued, “It does give a potential avenue for these alternative medicines in the therapy of cardiovascular disease. So altogether, it’s encouraging, but obviously, I approach the subject with a little bit of scepticism.”

Dr. Tadwalkar concurred, saying it’s critical to look into alternative treatments for cardiovascular illnesses.

Today’s patient is looking for a range of options and they want to have a specific treatment plan that’s tailored to their needs and circumstances,” he added. “This offers a slightly more individualized approach. And it can include all of the popular holistic treatments, including dietary adjustments, lifestyle changes, and all-natural cures combined.

I think it allows patients to feel more empowered because they can take a little bit more of an active role in their own care,” Dr. Tadwalkar continued. According to my observations, patients are frequently much more likely to be interested in conventional medication when they may adopt a complementary strategy that encourages the use of alternative medicines.

REFERENCES:

For Heart disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?cPath=77_99

Reduce the Dementia risk by strict blood pressure control.

Reduce the Dementia risk by strict blood pressure control.

The effects of intensive versus routine hypertension treatment on brain lesions were examined by researchers at the University of Texas Health Science Centre in San Antonio.

The researchers discovered that intensive therapy that maintains blood pressure within normal bounds is associated with a slowed progression of lesions using data from a previous study.

The study results could influence treatment strategies for hypertensive patients to lower the likelihood of lesions that can result in diminished cognitive performance with further research and trials.

Millions of people have hypertension, which can lead to strokes and brain lesions and compromise brain health.

An aggressive blood pressure regimen can slow the growth of white matter lesions in the brain, according to a recent study headed by UT Health San Antonio.

In contrast to patients with systolic blood pressure readings of 140 mm Hg, the researchers compared the MRI scans of individuals who maintained blood pressure levels below 120 mm Hg.

What is considered hypertension?

Millions of Americans suffer from the medical disease known as hypertension, sometimes known as high blood pressure. Nearly half of American adults have hypertension, which the Centres for Disease Control and Prevention claim contributed to more than 670,000 deaths in 2020.

Blood vessel damage and other health issues can result from high blood pressure. Heart attacks and strokes are two conditions brought on by hypertension.

The following blood pressure ranges are described by the American Heart Association:

For individuals, a normal blood pressure reading is defined as an upper number (systolic) less than 120 over a lower number (diastolic) of 80 mm Hg.

  • Blood pressure that is elevated is 120 to 129 over 80 or less.
  • Hypertension in stage 1 is defined as 130-139 above 80-89.
  • 140 over 90 or higher indicates stage 2 hypertension.

When the systolic and/or diastolic values exceed 180 and 120 respectively, a hypertension crisis ensues.

As the cardiologist, Dr. Kershaw Patel points out in the Houston Methodist podcast On Health, “When we talk about high blood pressure, we must realise it affects not just the heart, but also the brain, the kidneys, and other organs in the body.”

Although doctors frequently prescribe prescription drugs to treat high blood pressure, patients can also try to lower or normalise their blood pressure by making changes to their lifestyle.

Dr. Patel stated that lifestyle changes and then drugs are commonly used to manage high blood pressure. And it really comes down to two-thirds lifestyle and one-third medicine. By adjusting a few aspects of our lifestyle, we can significantly lower our blood pressure.

Blood pressure can be normalised by giving up smoking, consuming less alcohol, exercising, eating a low-sodium diet, and eating more fruits and vegetables.

lowering one’s blood pressure to 120

The American Academy of Family Physicians’ (AAFP) standard of care for hypertensive patients is to lower their systolic blood pressure to 140 mm Hg. This goal lowers the risk of cardiovascular death, according to the AAFP.

To assess the effect on white matter lesions (WMLs), the UT Health San Antonio researchers compared the normal treatment target to a more rigorous therapy. The goal of the rigorous treatment program was to lower participants’ systolic blood pressure to under 120 mm Hg.

The researchers examined data from 458 participants using information from the Systolic Blood Pressure Intervention Trial (SPRINT), which tracked participants for 4 years. Participants in the study were “aged 50 years or older with hypertension and without diabetes or a history of stroke,” according to the study’s authors.

At the start and conclusion of their trials, the researchers matched each participant’s treatment to their MRI images. They were searching for WMLs, a type of injury to the brain’s white matter that can result in cognitive impairment.

Treatment that is intensive lessens brain damage

According to the study’s findings, the intensive treatment group’s WML volume progression and fractional anisotropy (FA) declines were slower than those of the conventional treatment group.

The FA result is noteworthy since it represents a “measure of connectivity in the brain.” The right splenium, right tapetum, and left anterior corona radiata are a few of the brain areas that saw slower WML growth.

The study also demonstrates that aggressive blood pressure management may be able to maintain some myelin structure, which, according to the scientists, “ultimately slows the progression of injury patterns associated with dementia.”

According to research author Dr. Tanweer Rashid, who works with the Biggs Institute at UT Health San Antonio, “our study shows that specific areas have greater benefit, representing sensitive regions to track in future trials evaluating small-vessel disease.”

How white matter is impacted by blood pressure?

The study’s findings were discussed by Dr. Arun Manmadhan, a cardiovascular disease expert at Columbia University Irving Medical Centre in New York City.

“White matter lesions are abnormally damaged regions of tissue in the white matter of the brain. According to Dr. Manmadhan, they are frequently brought on by anomalies in the tiny blood arteries that provide oxygen and nutrients to the brain.”

Dr. Manmadhan provided more information on the study’s findings, namely how blood pressure may affect WMLs.

“The current report, which is a SPRINT-MIND substudy, examined the impact of stringent blood pressure management on changes in the brain’s white matter as determined by MRI.”

According to Dr. Manmadhan, the results here point to a potential benefit of tight blood pressure control in slowing the development and progression of white matter lesions, which are linked to a higher risk of dementia and cognitive decline.

Overall, according to Dr. Manmadhan, the study is an asset to the field of hypertension.

This study “adds to the already substantial body of literature that managing blood pressure is very important for not only preventing cardiovascular events but also in maintaining memory and cognition,” the author added.

REFERENCES:

For Dementia disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?cPath=77_478

A blood thinner that doesn’t increase bleeding risk.

A blood thinner that doesn’t increase bleeding risk.

Anticoagulants are crucial for avoiding harmful blood clots, but they also raise the possibility of severe bleeding. If additional research confirms the potential of a novel molecule, blood thinners may no longer increase the risk of bleeding in the future.

The novel drug deliberately targets just one clotting pathway as opposed to all clotting pathways to prevent thrombosis, allowing clotting to proceed without a risk of bleeding or toxicity.

Blood thinners, often known as anticoagulants, work to dissolve and prevent blood clots, semi-solid blood cell clumps, and other things that might obstruct blood flow. However, anticoagulants sometimes function too effectively, which prevents clotting altogether and causes excessive bleeding from the inside or outside.

In a recent study, scientists from the Universities of British Columbia (UBC) and Michigan introduced a novel substance called MPI 8 that may one day make anticoagulants significantly safer.

At the location of an internal or external wound, blood clots often develop, stop the bleeding, and enable the body to start healing. Internal clots can fill the bloodstream or prevent blood flow to vital organs like the heart, brain, and lungs when they become loose. A heart attack, stroke, or pulmonary embolism may be the outcome.

What are Blood thinners?

Blood clots, which can result in a heart attack or stroke, can be avoided by taking blood thinners by mouth, vein, or skin. If you have heart issues like a valve disease or an erratic heartbeat, you could require them.

Blood clots can obstruct the heart, lungs, or brain from receiving blood. You might need to take blood-thinning medicine to stop this.

It’s critical to follow the directions on the label precisely. The drug won’t be as effective if you don’t take it regularly. Extreme bleeding can result from taking too much.

What blood thinners do?

To prevent blood cells from clumping together in the veins and arteries, several drugs thin the blood. Others work to stop blood clots by lengthening the time it takes for them to form. These are referred to as antiplatelet and anticoagulant medications, respectively.

People who have been given a heart disease diagnosis frequently receive anticoagulant prescriptions from their doctors. The word “coagulate” is a medical phrase that implies “to clot.” By prolonging the time it takes for your blood to clot, these blood thinners prevent blood clots.

Clots are prevented from developing by anticoagulants. Common blood thinners that prevent clotting include:

  • warfarin (Jantoven, Coumadin)
  • Lovenox, enoxaparin
  • heparin

Newer anticoagulants with reduced risk of consequences from bleeding include:

  • Pradaxa’s dabigatran
  • (Eliquis) apixaban
  • Xarelto (rivaroxaban)

Antiplatelet medications, on the other hand, stop blood cells, known as platelets, from congregating and creating clots. These include:

  • aspirin
  • (Plavix) clopidogrel
  • periantine dipyridamole
  • (Ticlid) ticlopidine

What blood thinner is best for you will be decided by your doctor. The dosage you receive will be closely watched, and a prothrombin time (PT) test may occasionally be performed. Your INR, or international normalised ratio, is determined by this blood test.

The INR measures how quickly your blood clots. A person’s medical history determines the optimum INR rate for them. You can stop yourself from bleeding excessively or clotting too quickly by staying within your INR range.

To stop a blood clot from developing, medications that are anticoagulant and antiplatelet are both utilized. To break a blood clot that has already formed, like in the case of deep vein thrombosis (DVT) or pulmonary embolism, for instance, a class of drugs known as thrombolytics may be utilized.

Creating MPI 8 to focus on blood clots

Dr. Jay Kizhakkedathu, the study’s principal author, said: “This is very, very interesting and exciting work.”

Dr. Kizhakkedathu remarked, “You know, we have been doing this for many years, but we finally were able to uncover a molecule which is a blood thinner, but which could help a lot of people.

The chemicals involved in blood coagulation that the researchers concentrated on included polyphosphate. Dr. James Morrissey, one of the study’s co-authors, had previously identified it as a prospective therapeutic target.

Dr. Morrissey said in a news release why the research team decided to focus on polyphosphate, saying it may be “a safer target to go after with an antithrombotic drug because it would just slow down these clotting reactions — even if we take out 100% of the action of the polyphosphate.”

However, it can be challenging to target a single molecule in the blood. According to Dr. Kizhakkedathu, polyphosphate is a negatively charged molecule electrically. It is polyanionic, which means that it has several pockets of negative charge. An anionic molecule, on the other hand, has a single negative charge.

MPI 8 stands for “Macromolecular Polyanion Inhibitor 8.”

“Ionic charges are present throughout our bodies. Nearly every surface in our body is polyanionic, including the surfaces of cells and proteins, according to Dr. Kizhakkedathu. We require highly specialised agents that can bind to polyphosphate, a very precise polyanion.

Because there are so many negatively charged anions in the blood, previous attempts to target polyphosphate with cations, positively charged compounds, were toxic because they bound indiscriminately with so many of them.

According to Dr. Kizhakkedathu, the scientists were able to pinpoint a class of molecules known as the MPIs that possessed “very special properties.” “However, it raises the charge density once it has located its target. It binds very tightly and specifically, he continued.

A breakthrough finding might help future research.

As of now, MPI 8 has been tested on mice by the study’s authors, who discovered that it effectively prevents blood clots without being harmful or increasing the risk of bleeding.

For MPI 8, UBC and the University of Michigan have submitted a patent application with the goal of moving on to studies with larger animals and ultimately humans.

The team’s discovery, according to Dr. Kizhakkedathu, “will a help a lot of people if it gets into the clinical trials and approved.”

REFERENCES:

For Blood thinner medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=47

Longer naps may increase the risk of obesity & hypertension

Longer naps may increase the risk of obesity & hypertension

According to research, those who nap during the day for longer than 30 minutes appear to be more likely to be obese and have high blood pressure.

They observed that persons with shorter naps are less likely to develop high blood pressure.

Longer naps, according to specialists, may play a role in these illnesses because they can disturb both eating and sleeping patterns at night.

More than 30-minute naps during the midday may raise blood pressure, increase body mass index, and worsen diabetes and heart-related diseases, according to research.

The prevalence of high blood pressure was lower among people who took what are known as “power naps,” which are midday sleep sessions lasting 30 minutes or fewer.

Researchers from Brigham and Women’s Hospital in Boston evaluated more than 3,000 adults from a Mediterranean population—where midday naps, known as “siestas,” are common—for a recent study that was published in the journal Obesity.

The duration of siestas and their association with metabolic syndrome and obesity were investigated by the researchers.

According to studies, those who take siestas of at least 30 minutes are more likely than those who don’t to have higher blood pressure, a higher body mass index, and other diseases linked to diabetes and heart disease.

Additionally, compared to people who did not take a siesta, those who took brief naps were less likely to exhibit elevated systolic blood pressure. “Not all siestas are the same,” said Marta Garaulet, Ph.D., MS, a senior study author and a visiting professor in the Brigham and Women’s Hospital Division of Sleep and Circadian Disorders. “The health effects of a nap can depend on the length of time, position of sleep, and other particular factors.”

Obesity and Naps

According to Garaulet, the group previously conducted research in the UK and discovered that siestas were linked to a higher risk of obesity. The next step was to examine siestas in a nation where afternoon naps were more prevalent in culture.

According to Garaulet, “in this case, Spain, as well as how the duration of siestas is related to metabolic health.” The group notes that there are more than 1 billion obese people in the world, which is a rising health risk.

In the course of metabolic processes, how people digest food has a connection to fat accumulation in the body. Researchers suggested that studying how habits, such as napping, alter certain metabolic pathways, could contribute in the understanding of how habits affect health.

Findings from the napping research

The group looked at information from 3,275 persons in the Murcia region of Spain.

Participants at the University of Murcia had their baseline metabolic parameters assessed, and information about their naps and other lifestyle elements was gathered. No siestas, shorter than 30 minutes, and more than 30 minutes were the categories into which the subjects were split.

In comparison to those who did not take siestas, subjects who took longer naps had higher body mass indices and were more likely to have metabolic syndrome (MetS).

The extended nap group exhibited greater waist circumference, fasting glucose levels, systolic blood pressure (SBP), and diastolic blood pressure values as compared to the no-siesta group. Longer siestas were linked to later nighttime eating and sleeping, more energy consumed during lunch, and smoking.

Sleep and obesity

A lot of study has been done on the relationship between sleep and obesity, according to Becca Krukowski, PhD, a professor at the University of Virginia School of Medicine.

In contrast, Krukowski noted, “This article adds knowledge about sleep and health risks in a cultural context where naps are promoted among healthy people, across the lifespan, while also considering other potentially related factors, such as nap length and eating patterns.”

According to Krukowski, it’s probable that the health issues led to the lengthier sleeps rather than the other way around. The direction of these correlations cannot be determined from this study because it is cross-sectional. It’s likely that obese people sleep less soundly at night and require longer naps as a result.

The study, according to Krukowski, might be a first step towards more illuminating research.

“Previous studies have shown that weight loss interventions improve sleep quality,” said Krukowski. It could be interesting to look at whether weight loss is impacted by sleep therapies, such as controlling nap length and increasing nocturnal sleep.

More study is required on napping

The authors of the study acknowledged that it’s possible that some factors—rather than siestas per se—might be a result of obesity rather than being caused by siestas, as evidenced by a prior investigation of data from the UK Biobank that found a causal link between napping and obesity, particularly abdominal obesity, which they refer to as the most harmful type.

The link between siestas and health indices was found to be mediated by a number of statistically relevant lifestyle factors, according to the authors.

They urge further investigation into whether a little siesta is preferable to a long one, especially for people who smoke, have bad habits like sleeping in late or delaying meals, or who have delayed sleep patterns.

The Brigham’s Division of Sleep and Circadian Disorders’ Frank Scheer, PhD, a senior neuroscientist and professor in the Medical Chronobiology Programme, commented on the study’s findings in a statement. “This study shows the importance of considering siesta length and raises the question of whether short naps may offer unique benefits,” he said. Numerous institutions are starting to recognise the advantages of quick naps, mostly for work productivity but also more and more for overall health.

REFERENCES:

For High blood pressure medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=8

Can workplace discrimination result in high blood pressure?

Can workplace discrimination result in high blood pressure?

According to a recent study, those who feel discriminated against at work are far more likely to experience high blood pressure.

The results are consistent with earlier studies in which researchers found that even a small degree of employment discrimination can have an adverse effect on one’s physical and emotional well-being.

According to experts, employment discrimination must be reduced through the implementation of regulatory changes and cultural reforms.

Your blood pressure may increase if you feel discriminated against at work, and not only metaphorically.

Analysing the research’s data

The researchers looked at information from the Midlife in the United States Study (MIDUS) on American adults who had a range of educational backgrounds and occupations for this study. They examined information on 1,246 persons who were tracked from the study’s beginning in 2004 to its halfway point in 2006 without exhibiting signs of high blood pressure. About half of those examined were women and most were white.

They mainly fell into the following age groups:

  • not older than 45
  • aged 46 to 55
  • 56 or more

According to a study published this week in the Journal of the American Heart Association, people who report experiencing high levels of workplace discrimination were 54% more likely to acquire high blood pressure than those who reported experiencing low levels of such discrimination.

To estimate the prevalence of employment discrimination, researchers examined survey responses from 1,246 persons in the US who did not self-report having high blood pressure, often known as hypertension, at the start of the study.

Most of the participants were Caucasian, and they represented a variety of professions and educational levels. There were roughly equal numbers of males and women. Following that, participants were monitored for about 8 years.

A validated questionnaire was used to measure perceived workplace discrimination. Participants were questioned about their work experiences, including whether they felt treated unfairly, whether they felt monitored or ignored more than others, whether job promotions were appropriately rewarded, and how frequently they were exposed to racial, sexual, or ethnic discrimination or jokes.

Every inquiry received a score between 1 (never) and 5 (at least once each week). Participants were split into three groups based on their total scores: low, middle, or strong discrimination.

The outcomes?

After the trial, they discovered that 319 participants had high blood pressure after around eight years of the follow-up period.

People with “low workplace discrimination scores” were 22% less likely to report high blood pressure than those with “intermediate workplace discrimination exposure scores.”

Additionally, in comparison to individuals who had reported low workplace discrimination scores, those with high workplace discrimination exposure ratings were 54% more likely to report high blood pressure readings during the follow-up research period.

Dr. Jian Li, M.D., Ph.D., the lead study author and professor of work and health at the University of California, Los Angeles’ Fielding School of Public Health and School of Nursing, told Healthline that he initially predicted there would be a connection between high blood pressure and workplace discrimination before beginning this project.

He declared that he was “excited to see the association” between discrimination and such a significant increase in blood pressure.

The health effects of discrimination

In a sense, experts say, these results are not surprising because prior research has demonstrated that racism and prejudice can have major effects on both physical and mental health.

It appeared that employment discrimination, even at low levels, had an impact. When compared to individuals with low workplace discrimination ratings, those with intermediate values were still 22% more likely to report having high blood pressure.

Anjali Gowda Ferguson, PhD, a certified clinical psychologist, claimed that discrimination has “profound health impacts that are a result of an exacerbated stress response.”

“People can exhibit trauma symptoms, which essentially put the body in the fight-or-flight position. The physical health of people starts to suffer as a result of these protracted feelings of anxiety”.

Senior lecturer in cognitive science at Troy, New York’s Rensselaer Polytechnic Institute, Alicia Walf, PhD, concurred. Discrimination, according to her, is a “chronic psychosocial stressor” that demands attention.

Waif said that because people are discriminated against in settings other than the workplace, “the effects shown in this study of an increased risk of developing high blood pressure in individuals who reported that they faced discrimination at work has far-reaching consequences.” In addition, high blood pressure is an important indicator since it is associated with a higher risk of diseases other than cardiovascular disease, like immunological and metabolic problems.”

She continued, “I believe that this is an important first study examining the relationships between workplace discrimination and this one signal of the detrimental effects on health, such as high blood pressure. “I hope this inspires future research finding out if there are individual differences based on factors, like age and the type of discrimination faced,” the author says.

Manage discrimination leading to high blood pressure

What should you do if discrimination at work causes your blood pressure to rise or causes other changes to your cardiovascular health?

Li suggested that workers could use self-regulated stress reduction techniques like mindfulness exercises. According to him, studies show that “mindfulness-based stress reduction could lower blood pressure.”

Albert noted that while some people have better coping techniques than others when it comes to managing the effects of workplace discrimination on blood pressure, these measures can be beneficial for the individual.

“Those who have higher coping skills will have better biological responses, meaning they are less likely to develop high blood pressure and other forms of cardiovascular disease,” she said.

Albert emphasised that this places a heavy burden on the individual.

Sincerity be damned, I’ve always had a problem with coping since it tends to focus on the individual rather than the systems and structural elements. Both are necessary, she noted. Interventions that deal with systemic prejudice are necessary, as are interventions that support people as they adjust to having fewer biological effects.

Most adversely affected by discrimination at work

Li responded that a wide spectrum of groups are affected and at danger for the detrimental effects of workplace discrimination.

A person may be the subject of discrimination due to a variety of reasons, including their color, age, gender, sexual orientation, religion, national origin, presence of a certain health condition, or outward appearance.

One noted weakness of the new study is that non-white people with lower levels of education who hold positions where they have less power over their workplaces tended to opt out of the follow-up questioning sessions. Future research should, according to Li, fill some of these gaps.

Albert pointed out that it is significant to take into account the fact that the majority of the participants in this study self-identified as white.

It isn’t difficult to imagine that those same groups would also experience some of the worst cases of discrimination, and, as a result, these detrimental effects on cardiovascular health, she said, given the larger structural barriers the most vulnerable members of our society face because of their race and ethnicity, their sex and gender identity, and their sexual orientation, to name a few examples.

There isn’t a lot of information available on this as of yet, she claimed. She cited studies on the effects of discrimination on the cardiovascular health of Black women that she had conducted and presented.

According to Albert, there is a 30–50% higher risk of coronary heart disease, which is what causes heart attacks, as a result of discrimination.

REFERENCES:

For Blood pressure medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=53

Is Strength training effective for managing blood pressure.

Is Strength training effective for managing blood pressure.

Hypertension, often known as high blood pressure, is a common ailment that, if left untreated, can cause major issues. Medication and lifestyle changes can both be used to address high blood pressure.

A systematic evaluation and meta-analysis of the available data revealed that strength training may be a useful non-drug alternative for the management of high blood pressure. Its effectiveness, however, is influenced by variables including intensity and duration.

People who have hypertension or high blood pressure are susceptible to some long-term problems. Blood pressure can be lowered and a person’s risk of problems can be decreased with early management.

The greatest strategies for modifying one’s lifestyle to lower blood pressure are constantly being researched. How strength training affects blood pressure is one topic of interest. Recent systematic reviews and meta-analyses have demonstrated the blood pressure-lowering benefits of strength training.

Researchers found that strength training appears to be most useful when it entails working out at least twice per week for at least two months at a moderate to strenuous level.

High blood pressure and treatments

The force the heart uses to pump blood throughout the body is measured by blood pressure. The force blood applies to blood vessel walls as the heart contracts is known as systolic blood pressure. When the heart relaxes, the blood pressure in the diastole is the force.

It’s critical that blood pressure maintain a healthy range. Stroke, heart attack, or kidney failure are just a few of the severe problems that high blood pressure can cause. Dr. John Higgins, a sports cardiologist from UTHealth Houston and a non-study author, observed:

“Hypertension is a significant risk factor for developing heart disease that, if not managed properly, can result in early coronary artery disease (CAD), stroke, peripheral arterial disease, atrial fibrillation, and heart failure. Increased morbidity and death are linked to all these disorders.

Aside from taking medicine, managing high blood pressure entails making changes to one’s lifestyle. Losing weight, giving up smoking, and exercising are a few examples of lifestyle changes. Individualized treatment programs for people with high blood pressure can be created in collaboration with their doctors.

Dr. Rohini Manaktala, a cardiologist with Memorial Hermann Medical Group and an independent study author, stated that “following a healthy way of living with daily physical activity, maintaining a normal weight, consuming alcohol in moderation, and refraining from tobacco use are all ways to control an individual’s blood pressure.”

Using strength training to manage hypertension

In this systematic review and meta-analysis, researchers investigated the effects of strength training on high blood pressure levels by reviewing several papers. Through several databases, including PubMed, the Cochrane Library, and the World Health Organisation, they discovered studies. Fourteen randomized controlled studies that satisfied inclusion requirements were included in their study.

253 hypertensive people in all were included in the study and analysis. Participants were just about sixty years old on average.

Giovana Rampazzo Teixeira, Ph.D., the senior author of the study and a professor at UNESP – So Paulo State University’s School of Technology and Sciences, said: “We used randomised clinical studies that used strength training as a treatment for arterial hypertension in hypertensive individuals.”

The following criteria were determined to be the most conducive to strength training’s ability to lower blood pressure in participants:

At least twice a week, individuals engaged in strength exercises that ranged from moderate to strenuous intensity. The intervention lasted at least eight weeks. As outlined by Dr. Teixeir:

“We found that people under 59 years old experienced a more notable drop in blood pressure during the physical training phase. People between the ages of 60 and 79 reported a less noticeable but still discernible difference. Thus, we emphasize that strength training provides advantages for both young and old.

Dr Teixeria continued, “Professionals who are faced with a hypertensive subject in clinical practise or even in the day-to-day at the gym will be able to use strength training as a treatment for arterial hypertension, knowing what the necessary variables for this are to be achieved, and always taking into consideration the goals of that subject.”

How to lower blood pressure

Studies like this one, according to Dr. Fahmi Farah (MD), of Bentley Health, can give cardiologists like her another tool when communicating with the patients they care for.

We have always known that exercise lowers the chance of developing cardiovascular disease, but this study gives us additional proof and confidence to tell our patients about the benefits of exercise and encourage them to try it for themselves.

Farah and her peers in the sector are aware that strength training can provide health hazards or be prohibitively expensive or difficult to get owing to geography. is not accessible to all.

“I would say that on a population, a country, and a government level, I think the help needs to come from higher up so that we can make it more practical for everyone to be able to afford working out.”

Even for individuals who can exercise, Makowski advises against becoming overly ambitious or pushing oneself beyond their limits.

Strength training may be done at many degrees, and it’s not always what we imagine when we think of someone bench pressing a lot of weight elastic bands, light dumbbell weights, and bodyweight movements known as isometrics are some examples.

But before beginning weight training as an intervention for high blood pressure, every expert for this article advised the same thing: make sure you’ve spoken with your doctor.

Data limitations and clinical implications

This analysis and assessment does have some restrictions. First, research involving the use of blood pressure-lowering drugs were not disregarded. This fact might have affected how their analysis turned out.

Second, while multiple control groups were employed in the studies that were included, the researchers only paid attention to the blood pressure readings of participants who had high blood pressure. The ability of researchers to compare how strength training would benefit men and women differently was also constrained. Researchers also point out that there may be publication bias in the available studies.

Dr. Manaktala made the following assumptions regarding how strength training might be used to reduce high blood pressure based on the study’s findings:

Strength training is simple to incorporate into a person’s regular routine. The most crucial factor is constancy. A decent first exercise method to lower blood pressure would be a moderate to strenuous workout, 2 to 3 times per week.

It’s also crucial to remember that each person’s use of strength training may seem different. To perform a strength training programme safely, people might ask doctors and other experts for assistance.

Dr. Higgins stated that it is wise to consult with medical professionals before beginning a strength training programme to ensure that it is safe to do so and to get their advice on the appropriate level of intensity.

REFERENCES:

For Blood pressure medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=53

Dementia due to brain damage by high blood pressure?

Dementia due to brain damage by high blood pressure?

According to research, some aggressive blood pressure medicines can benefit brain health. As per them, the therapies function by opening up neural pathways in the perivascular regions of the brain.

According to experts, a balanced diet, regular exercise, enough sleep, and avoiding overstimulation are all important components of maintaining excellent brain health. Researchers may be able to detect people with severe cognitive impairment with the aid of additional research.

Dementia, a general term for a multitude of illnesses affecting memory loss and cognitive deterioration, affects more than 55 million individuals worldwide. Scientists are unsure of the exact aetiology of dementia, but they do know that certain factors can affect whether or not someone gets dementia. High blood pressure is one of these.

According to earlier studies, those who have high blood pressure are more likely to experience dementia, including Alzheimer’s disease.

Researchers from the University of Edinburgh in the United Kingdom and Jagiellonian University Medical College in Krakow, Poland, have now identified the precise regions of the brain that may be harmed by high blood pressure and are connected to the onset of dementia.

What is blood pressure? 

The amount of power the heart exerts to pump blood through the arteries is measured as a person’s blood pressure.

The doctor gets two distinct readings while taking your blood pressure. The highest figure reflects the systolic pressure experienced as the heart pumps blood into the arteries. The diastolic pressure, which the heart experiences between heartbeats, is represented by the bottom number. They are both expressed in millimetres of mercury (mmHg).

For instance, the systolic and diastolic pressures of normal blood pressure are both less than 120 and 80 mmHg, respectively (but more than 90mmHg systolic and 60mmHg diastolic).

High blood pressure is seen as beginning when the systolic and diastolic pressures both rise to 130 and 80, respectively. Stage 2 high blood pressure is defined as systolic and diastolic pressures of at least 90mmHg and 140mmHg, respectively.

High blood pressure

Hypertension, also referred to as high blood pressure, develops when the amount of effort required for blood to flow through the arteries is too great.

This may occur if plaque inside the artery walls, which contains cholesterol, causes the arteries to become damaged or narrower.

A person’s chance of acquiring high blood pressure may be increased by a number of variables, such as:

  • unsound diet
  • obesity
  • inactivity
  • Using tobacco or alcohol
  • genetics
  • certain illnesses, like diabetes

How does high blood pressure affect the brain? 

The lead author of this study and professor of cardiovascular medicine at Jagiellonian University Medical College in Krakow, Poland, and the University of Edinburgh in the United Kingdom, Prof. Tomasz Guzik, believes that having high blood pressure can negatively impact the structure and operation of the brain in a variety of ways.

“For example, hypertension can have a serious influence on your brain’s blood vessels, causing them to change in shape, stiffen, and form clogged arteries. “Small vessel disease” is a condition that results from the malfunction of smaller blood vessels in the brain caused by high blood pressure, which is passed from bigger to smaller blood vessels.

“High blood pressure not only impacts the flow of blood to the brain, but it also speeds up pathological processes including neurodegeneration and inflammatory activationTrusted Source. Dementia, memory loss, and other cognitive impairments are all caused by these conditions, said Tomasz Guzik, Ph.D.

Furthermore, according to Prof. Guzik, excessive blood pressure might harm the brain’s white matter.

He said that damage to this area can result in poor cognitive performance and raise the risk of stroke. “The white matter is formed of nerve fibres that transfer information across different brain regions,” he said.

According to him, this emphasises how crucial it is to keep blood pressure under control in order to avoid white matter damage and the accompanying cognitive problems.

Blood pressure study

The individuals were split into two groups by the scientists for their analysis. With a goal of 120 mm Hg systolic pressure, 243 patients in one group had highly intense treatment for high blood pressure.

The second group, consisting of 199 individuals, received routine care with a 140 mm Hg goal. Pre- and post-study MRIs were used to compare the number of perivascular spaces in each participant’s brain.

The innermost layer of the brain contains spaces filled with cerebrospinal fluid known as Virchow-Robin spaces, or perivascular spaces (PVS), according to Dr. Sandra Narayanan, a vascular neurologist and neuro-interventional surgeon at the Pacific Stroke & Neurovascular Center at Pacific Neuroscience Institute in California.

They may get bigger as a result of neurodegenerative processes, demyelinating diseases, inflammation, or ageing. They aid in clearing the brain of metabolic waste and water, she said.

The American Heart Association states that a normal blood pressure reading is less than 120/80 mm Hg. Elevated blood pressure is defined for adults as 120 to 129 mm Hg for the systolic pressure (the top number) and less than 80 mm Hg for the diastolic pressure.

High blood pressure is defined as a persistently high systolic pressure of 130 mm Hg or higher, or a diastolic pressure of 80 mm Hg or higher.

Hypertension-dementia link

Thousands of participants from the UK Biobank, COGENT, and the International Collaboration for Blood Pressure provided observational data for this study, which Prof. Guzik and his team conducted using a combination of brain magnetic resonance imaging (MRI), genetic analysis, and observational data.

After examination, scientists discovered alterations in nine regions of the brain connected to both deteriorating cognitive function and elevated blood pressure.

The putamen, which is in charge of learning and motor control, is one of these regions. Alzheimer’s disease and putamen dysfunction are related, according to earlier study.

White matter regions, the anterior thalamic radiation, the anterior corona radiata, and the anterior limb of the internal capsule were also affected by high blood pressure. 

Both basic and complicated behaviours are planned and carried out by the anterior thalamic radiation, whereas the anterior corona radiata supports decision-making and emotion regulation. Moreover, the internal capsule’s anterior limb supports motivation, decision-making, and cognitive processing.

What you can do to improve brain health?

According to Narayanan Sajd, “many risk factors for neurodegenerative illnesses, such senior age, tend to be progressive.” There are significant potential clinical consequences on quality and quantity of life for these debilitating and pervasive illnesses if some of the associated clinical aspects are changeable.

According to the study’s findings, maintaining a healthy blood pressure level is crucial for maintaining a healthy brain.

The Mediterranean diet, which is low in fat and abundant in fruits and vegetables, is one example of a nourishing diet that the Alzheimer’s Association recommends. It’s also crucial to challenge your intellect by learning something new.

Behavioral scientist, relationship expert, and developer of the Happiness Hypothesis Method Clarissa Silva advises incorporating the following into your life:

  • Exercise. Daily aerobic activity for at least 30 minutes encourages the growth of new neurons in the brain.
  • Sleep. Regular sleeping patterns prevent the onset of brain fog and can make it worse throughout the day.
  • Overstimulation. Work productivity may be hampered by multitasking, which also adds to our brain’s ongoing overstimulation. Neuroplasticity in the brain is enhanced by concentrating on one task at a time and taking a break before moving on to the next one.
  • Unattended trauma. Trauma affects cognitive performance, self-esteem, and decision-making. Working with a qualified specialist to address trauma can start the process of reversing current cognitive impairment and preventing further degenerative disorders.

According to Silva, limiting screen time can aid in neuron regeneration. “Setting up a routine. At first thing in the morning and an hour before going to bed, try to cut back on checking your gadget. The constant overstimulation that we experience throughout the day needs to be repaired in our brains.

REFERENCES:

For more details, kindly visit below.